3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34735879 | MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway. | 2021 Oct 23 | 1 |
2 | 27599525 | Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation. | 2017 Feb | 3 |
3 | 25326806 | Combine MEK inhibition with PI3K/mTOR inhibition exert inhibitory tumor growth effect on KRAS and PIK3CA mutation CRC xenografts due to reduced expression of VEGF and matrix metallopeptidase-9. | 2015 Feb | 1 |